Showing results (1591-1600 of 1,709) with videos related to

Sort By:
Pageof 171
BMC Medicine|August 29, 2013
A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathwaysRobert P Anderson, Margaret J Henry, Roberta Taylor, et al.
Journal of Cellular Physiology|December 6, 2018
RUNX1-dependent mechanisms in biological control and dysregulation in cancerDeli Hong, Andrew J Fritz, Jonathan A Gordon, et al.
Science Advances|August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac diseaseGautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.
Nature Neuroscience|April 25, 2017
Amygdala inputs to prefrontal cortex guide behavior amid conflicting cues of reward and punishmentAnthony Burgos-Robles, Eyal Y Kimchi, Ehsan M Izadmehr, et al.
Journal of Cellular Physiology|March 18, 2020
RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cellsAndrew J Fritz, Deli Hong, Joseph Boyd, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemiaAndrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Nature Communications|August 25, 2022
Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistanceMark A Tye, N Connor Payne, Catrine Johansson, et al.
Plos One|August 27, 2015
Patterns and Variation in Benthic Biodiversity in a Large Marine EcosystemSusan E Piacenza, Allison K Barner, Cassandra E Benkwitt, et al.
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humansJ R Atack, K A Wafford, L J Street, et al.
Pageof 171